Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Surgery Partners (SGRY) Income from Continuing Operations (2016 - 2025)

Surgery Partners' Income from Continuing Operations history spans 12 years, with the latest figure at 29000000.0 for Q4 2025.

  • For Q4 2025, Income from Continuing Operations rose 162.23% year-over-year to 29000000.0; the TTM value through Dec 2025 reached 98900000.0, up 691.2%, while the annual FY2025 figure was 98900000.0, 691.2% up from the prior year.
  • Income from Continuing Operations for Q4 2025 was 29000000.0 at Surgery Partners, up from 25300000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 57700000.0 in Q2 2023 and bottomed at 46600000.0 in Q4 2024.
  • The 5-year median for Income from Continuing Operations is 23800000.0 (2022), against an average of 20220000.0.
  • The largest YoY upside for Income from Continuing Operations was 1925.0% in 2024 against a maximum downside of 199.79% in 2024.
  • A 5-year view of Income from Continuing Operations shows it stood at 42900000.0 in 2021, then crashed by 45.69% to 23300000.0 in 2022, then skyrocketed by 100.43% to 46700000.0 in 2023, then tumbled by 199.79% to 46600000.0 in 2024, then soared by 162.23% to 29000000.0 in 2025.
  • Per Business Quant, the three most recent readings for SGRY's Income from Continuing Operations are 29000000.0 (Q4 2025), 25300000.0 (Q3 2025), and 44900000.0 (Q2 2025).